blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2838914

EP2838914 - HUMAN AMYLIN ANALOGUES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.04.2018
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  12.05.2017
FormerGrant of patent is intended
Status updated on  28.02.2017
FormerExamination is in progress
Status updated on  08.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2015/09]
Inventor(s)01 / DAHL, Kirsten
Præstetoften 7A
2765 Smørum / DK
02 / SCHÄFFER, Lauge
Hjortekærsvej 168
2800 Lyngby / DK
03 / KRUSE, Thomas
Tibbevangen 78
2730 Herlev / DK
 [2017/24]
Former [2015/09]01 / DAHL, Kirsten
Præstetoften 7A
DK-2765 Smørum / DK
02 / SCHÄFFER, Lauge
Hjortekærsvej 168
DK-2800 Lyngby / DK
03 / KRUSE, Thomas
Tibbevangen 78
DK-2730 Herlev / DK
Application number, filing date13723681.619.04.2013
[2017/24]
WO2013EP58165
Priority number, dateEP2012016469219.04.2012         Original published format: EP 12164692
US201261637806P24.04.2012         Original published format: US 201261637806 P
[2015/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013156594
Date:24.10.2013
Language:EN
[2013/43]
Type: A1 Application with search report 
No.:EP2838914
Date:25.02.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 24.10.2013 takes the place of the publication of the European patent application.
[2015/09]
Type: B1 Patent specification 
No.:EP2838914
Date:14.06.2017
Language:EN
[2017/24]
Search report(s)International search report - published on:EP24.10.2013
ClassificationIPC:C07K14/575
[2015/09]
CPC:
C07K14/575 (EP,CN); A61P1/04 (EP); A61P1/14 (EP);
A61P25/28 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P9/10 (EP); A61P9/12 (EP);
A61K38/00 (EP,CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/09]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANALOGE VON HUMANEM AMYLIN[2017/11]
English:HUMAN AMYLIN ANALOGUES[2015/09]
French:ANALOGUES DE L'AMYLINE HUMAINE[2017/11]
Former [2015/09]MENSCHLICHE AMYLIN-ANALOGA
Former [2015/09]ANALOGUES D'AMYLINE HUMAINE
Entry into regional phase19.11.2014National basic fee paid 
19.11.2014Designation fee(s) paid 
19.11.2014Examination fee paid 
Examination procedure19.11.2014Examination requested  [2015/09]
05.06.2015Amendment by applicant (claims and/or description)
16.09.2015Despatch of a communication from the examining division (Time limit: M04)
13.11.2015Reply to a communication from the examining division
29.01.2016Despatch of a communication from the examining division (Time limit: M06)
02.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.11.2016Reply to a communication from the examining division
01.03.2017Communication of intention to grant the patent
23.03.2017Fee for grant paid
23.03.2017Fee for publishing/printing paid
23.03.2017Receipt of the translation of the claim(s)
Divisional application(s)EP16173530.3  / EP3109256
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.09.2015
Opposition(s)15.03.2018No opposition filed within time limit [2018/21]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.11.2016Request for further processing filed
08.11.2016Full payment received (date of receipt of payment)
Request granted
21.11.2016Decision despatched
Fees paidRenewal fee
30.04.2015Renewal fee patent year 03
02.05.2016Renewal fee patent year 04
02.05.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.04.2013
AL14.06.2017
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
[2020/34]
Former [2020/31]HU19.04.2013
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2020/28]HU19.04.2013
AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/52]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
RO14.06.2017
RS14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/39]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RO14.06.2017
RS14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/21]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RO14.06.2017
RS14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/11]AT14.06.2017
CZ14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RO14.06.2017
RS14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/10]AT14.06.2017
CZ14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RO14.06.2017
RS14.06.2017
SK14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2018/09]EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RS14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/50]FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RS14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/49]FI14.06.2017
HR14.06.2017
LT14.06.2017
NO14.09.2017
GR15.09.2017
Cited inInternational search[AD] WO2010046357  (NOVO NORDISK AS et al.)
 [A] WO2007104789  (NOVO NORDISK AS et al.)
 [AD] WO2009034119  (NOVO NORDISK AS et al.)
 [A] US5739106  (RINK TIMOTHY J et al.)
 [A]   RYAN GINA ET AL: "Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.", DRUG DESIGN, DEVELOPMENT AND THERAPY 2009, vol. 2, 2009, pages 203 - 214, XP002689451, ISSN: 1177-8881

DOI:   http://dx.doi.org/10.2147/DDDT.S3225
by applicantWO2010046357
 WO2009034119
   NEEDLEMAN, S.B.; WUNSCH, C.D., JOURNAL OF MOLECULAR BIOLOGY, vol. 48, 1970, pages 443 - 453
   MYERS; W. MILLER: "Optimal Alignments in Linear Space", CABIOS (COMPUTER APPLICATIONS IN THE BIOSCIENCES, vol. 4, 1988, pages 11 - 17
   KURTZHALS, BIOCHEM.J., vol. 312, 1995, pages 725 - 731
   AHERN. T.J.; MANNING M.C.: "Stability of Protein Pharmaceuticals", 1992, PLENUM PRESS
   REMINGTON'S PHARMACEUTICAL SCIENCES, 1985
   "Remington: The Science and Practice of Pharmacy", 1995
   WILLIAMS; POLLI, J. PARENTERAL SCI. TECHNOL., vol. 38, 1984, pages 48 - 59
   MASTERS: "Spray-Drying Handbook", 1991, LONGMAN SCIENTIFIC AND TECHNICAL, pages: 491 - 676
   BROADHEAD ET AL., DRUG DEVEL. IND. PHARM., vol. 18, 1992, pages 1169 - 1206
   MUMENTHALER ET AL., PHARM. RES., vol. 11, 1994, pages 12 - 20
   CARPENTER; CROWE, CRYOBIOLOGY, vol. 25, 1988, pages 459 - 470
   ROSER, BIOPHARM., vol. 4, 1991, pages 47 - 53
   YU J; CHIEN YW.: "Pulmonary drug delivery: Physiologic and mechanistic embodiments", CRIT REV THER DRUG CARR SYS, vol. 14, no. 4, 1997, pages 395 - 453
   NAIKI ET AL., ANAL. BIOCHEM., vol. 177, 1989, pages 244 - 249
   LEVINE, METHODS. ENZYMOL., vol. 09, 1999, pages 274 - 284
   NIELSEN ET AL., BIOCHEMISTRY, vol. 40, 2001, pages 6036 - 6046
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.